Interasma is the Global Asthma Association focused on all aspects of asthma which bridges the gap between academia and the world of clinical practice.
- Tweets85.3K
- Following310
- Followers2.5K
- Likes10.4K
ALT Adults with #asthma who used #proton #pump #inhibitors had greater risks for #exacerbations and other negative outcomes than those who did not, according to an abstract presented at the #CHEST Annual Meeting. https://www.healio.com/news/allergy-asthma/20261020/proton-pump-inhibitor-use-linked-to-exacerbations-in-asthma
ALT #Ianalumab for the Treatment of Patients with #Sjögren’s #Disease | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2601088
ALT Patients who used #depemokimab for uncontrolled #asthma experienced improved symptoms, activity, impact on daily life and well-being through 52 weeks, according to a poster presented at the #CHEST Annual Meeting. https://www.healio.com/news/allergy-asthma/20261020/improvements-in-quality-of-life-in-asthma-emerge-earlypersist-with-depemokimab
ALT #Tezepelumab significantly improved histologic #remission and #dysphagia symptoms at 24 and 52 weeks compared with placebo among individuals with #eosinophilic #esophagitis. https://www.healio.com/news/gastroenterology/20261022/tezepelumab-sustains-clinical-benefit-for-eoe-remission-dysphagia-relief-at-52-weeks
ALT A #prescription-only, superpotent #corticosteroid was found in one-third of select #OTC products purchased online in the United States for inflammatory skin conditions, according to a study published in #JAMA Network Open. https://www.healio.com/news/dermatology/20261020/select-overthecounter-skin-products-contain-undisclosed-prescriptionstrength-steroid
ALT The #Xolair/#omalizumab #biosimilar #Omlyclo, #FDA approved for the treatment of four allergic and inflammatory conditions, is commercially available in the U.S., according to a press release. https://www.healio.com/news/allergy-asthma/20261020/xolair-biosimilar-omlyclo-commercially-available-in-us
ALT Real-world safety of personalized #telemedicine-delivered #sublingual #immunotherapy: reported adverse events across 18,398 patient-years. Open Access. https://ivancevichmd.blogspot.com/2026/10/real-world-safety-of-personalized.html
ALT Diagnosing Otitis Media — Otoscopy and Cerumen Removal | NEJM https://www.nejm.org/doi/full/10.1056/NEJMvcm0904397
ALT #AstraZeneca-#Amgen #Asthma Drug Hits 69% #Remission in #Esophageal Disease Trial. https://www.medscape.com/s/viewarticle/astrazeneca-amgen-asthma-drug-hits-69-remission-esophageal-2026a10013fj
ALT #Allergies and #Autoimmune #Diseases: New Clues to a Shared #Immune #Dysfunction.https://www.medscape.com/viewarticle/allergies-and-autoimmune-diseases-new-clues-shared-immune-2026a10013ge
ALT COVID-19 #vaccination shows limited impact on persistent #post-#COVID-19 #smell, #taste problems. https://onlinelibrary.wiley.com/doi/10.1002/lio2.70589
ALT The list of teams who competed
ALT Congratulations to our Winning Teams! (left to right) University of the Philippines - Philippine General Hospital; Bambino Gesu Pediatric Hospital (Italy); Universitas Indonesia; and Gaia and Espinho Local Health Unit (ULSGE) (Portugal)
ALT (Left to Right) Mario Morais-Almeida, Hidehisa Saeki, Motohiro Ebisawa, Soo Jong Hong, and Bryan L. Martin.
ALT Former Presidents of WAO (left to right): Profs. Motohiro Ebisawa, Lanny J. Rosenwasser, Ignacio J. Ansotegui, Allen P. Kaplan, Ruby Pawankar, G. Walter Canonica, Bryan L. Martin.
ALT Annual #asthma #exacerbation rates improved for patients who used #tezepelumab for severe, uncontrolled asthma regardless of their blood #neutrophil counts, according to an abstract presented at #CHEST 2026. https://www.healio.com/news/allergy-asthma/20261020/asthma-exacerbations-fall-with-tezepelumab-across-eosinophil-neutrophil-counts
ALT Real-world effectiveness of #dupilumab in patients with severe #asthma in Europe: Findings from the EU-ADVANTAGE study. Open Access. https://www.resmedjournal.com/article/S0954-6111(26)00580-9/fulltext
